Boxed warnings for dermatologic JAK inhibitors: are they standardized worldwide?

2024-9-18

Postoperative risk assessment of post-inflammatory hyperpigmentation and the efficacy of delayed prevention following 532 nm Q-switched Nd:YAG laser treatment of solar lentigines: a randomized controlled study

2024-9-12

Biodegradable polymers and platelet-rich plasma causing visual impairment: a literature review

2024-9-12

Correction

2024-9-11

Exploring the effect of deucravacitinib in patients with palmoplantar pustular psoriasis

2024-9-10

Report of successful treatment of follicular occlusion triad with adalimumab and research progress on biologic therapy for follicular occlusion triad

2024-9-9

Efficacy and safety of compound glycyrrhizin combined with topical minoxidil for alopecia areata: a systematic review and meta-analysis of randomized controlled trials

2024-9-4

Frequency and outcomes of treatment dose escalation with biologics in moderate-to-severe psoriasis: a Swedish register study

2024-9-4

Janus kinase inhibitors and adverse events of acne in dermatologic indications: a systematic review and network meta-analysis

2024-9-1

Patient perspective on symptoms of Notalgia paresthetica: subpopulation results from the Neuropathic Itch Patient Survey (NIRVE)

2024-8-27

A case of refractory anti-MDA5-positive amyopathic dermatomyositis successfully treated with upadacitinib

2024-8-27

Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study – IL PSO (Italian Landscape Psoriasis)

2024-8-20

Emerging DNA & RNA editing strategies for the treatment of epidermolysis bullosa

2024-8-18

The treatment of infantile giant café au lait spot using golden parameter therapy with a high fluence 1064-nm Q-switched Nd: YAG laser

2024-8-12

Treatment burden and the perspectives of patients with psoriasis using topical treatments: results from a national survey of adults with psoriasis in the United States

2024-8-11

The role of piperacillin/tazobactam in the treatment of Hidradenitis suppurativa

2024-8-5

Prescribing patterns and persistence of biological therapies for psoriasis management: a retrospective cohort study from Saudi Arabia

2024-8-5

Tradeoffs and decision-making in moderate to severe psoriasis for oral versus injectable treatments: data from patients and dermatologists in Australia

2024-7-30

Systematic review on antipruritic therapies for patients with Epidermolysis bullosa

2024-7-28

Evaluation of β2-microglobulin in the condition and prognosis of psoriasis patients

2024-7-28

Efficacy and safety of a novel monopolar radiofrequency device with a continuous water-cooling system in patients with age-related facial volume loss

2024-7-28

Utilizing artificial intelligence technology with emotional intelligence in clinical office visits

2024-7-23

Long-term quality of life outcomes from a phase 4 study of tildrakizumab in patients with moderate-to-severe plaque psoriasis in a real-world setting

2024-7-22

Association between genetically proxied PPARG activation and psoriasis vulgaris: a Mendelian randomization study

2024-7-21

Molecular mechanisms and drug therapy of metabolism disorders in psoriasis

2024-7-16

A 52-week follow-up, multi-center, randomized, double-blinded comparison of efficacy and safety of two hyaluronic acid fillers for the treatment of moderate-to-severe nasolabial folds in Chinese population

2024-7-14

Botanical extract combined with minoxidil improve hidrotic ectodermal dysplasia caused by p.G11R mutations: a case report

2024-7-11

Characterization of psoriasis patients in special body areas: real-world evidence from the Chinese Psoriasis Standardized Diagnosis and Treatment Center

2024-7-11

The development and initial evaluation of conversation cards for optimizing consultations for patients with atopic dermatitis

2024-7-9

Treatment of patients with evidence of mast cell-mediated itch in the absence of hives with omalizumab

2024-7-7

Risk of neutropenia in psoriasis patients prescribed anti-IL-23 antibody in comparison with anti-IL-17 antibody or adalimumab based on real-world data from the MID-NET ^® in Japan

2024-7-4

Upadacitinib 30 mg for the optimal management of moderate-to-severe atopic dermatitis: a 52-week single-center real-world study

2024-7-4

Correction

2024-7-2

Estimating the healthcare burden of Prurigo Nodularis in England: a CPRD database study

2024-6-30

A case report of bullous pemphigoid following secukinumab therapy for a patient with psoriasis

2024-6-30

Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials

2024-6-30

Review: the spectrum of antimicrobial resistance in bacteria isolated from wounds of patients with epidermolysis bullosa

2024-6-27

Evaluating prevalence and consequence of residual disease in individuals with psoriasis receiving apremilast treatment: results from a US patient survey

2024-6-24

Cost per response analysis of deucravacitinib versus apremilast and first-line biologics among patients with moderate to severe plaque psoriasis in the United States

2024-6-24

Health disparities in psoriasis: geographic barriers to access in the United States

2024-6-24

Preliminary analysis of the efficacy of Mohs micrographic surgery combined with photodynamic therapy in a case of noninvasive extramammary Paget’s disease

2024-6-19

Psoriasis healthcare during the COVID-19 pandemic: a survey among psoriasis patients (PsoCovidCare)

2024-6-19

Successful serial plasmapheresis for solar urticaria, a case report and literature review

2024-6-16

A multicenter, double-blind, randomized, parallel-group, active-controlled, phase 3 clinical trial to compare the effectiveness and safety of two botulinum toxin type A formulations for improving moderate to severe glabellar wrinkles in Asians

2024-6-16

Bibliometric analysis and description of research trends in the treatment of psoriasis with biologic agents in the past two decades (2004–2023)

2024-6-16

Unmet needs in treating itch: reaching beyond eczema

2024-6-13

Expert consensus on unmet needs, referral criteria and treatment goals for hidradenitis suppurativa in Saudi Arabia

2024-6-11

Behcet’s-like disease induced by secukinumab in a patient with psoriasis: a case report and literature review

2024-6-10

Chart review study of real-world clinical outcomes in patients with cutaneous T-cell lymphoma treated with extracorporeal photopheresis in the US in 2017–2019

2024-6-9

Racial differences in access to psoriasis biologics

2024-6-9